Fractionated Vs Single Dose Injection for Spinal C-Section in Patients With Pregnancy-Induced Hypertension

Sponsor
Indonesia University (Other)
Overall Status
Completed
CT.gov ID
NCT03693638
Collaborator
(none)
42
1
2
4.9
8.5

Study Details

Study Description

Brief Summary

The aim of this study was to compare haemodynamic changes, total dose of ephedrin requirement, and level of sensory blockade between fractionated dose and single dose spinal anesthesia injection in obstetric patients with pregnancy-induced hypertension who underwent Caesarean section

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Subjects were given informed consent before enrolling the study and randomized into two groups; single dose (SD) and fractionated dose (FD). All subjects will receive spinal anesthesia with 2,5 ml of 10 mg bupivacaine hyperbaric 0,5% and fentanyl 25 mcg. After IV cannulas (18 - 20 G) were properly placed, premedication with intravenous (IV) ranitidine 50 mg and metoclopramide 10 mg were given. Additional IV access was added if MgSO4 must been continuously administered intravenously perioperatively. Standard monitor device were placed after patients had been transferred to operating room. Additional premedication such as intravenous midazolam 0.02 mg/BW or fentanyl 1 mcg/BW were given if the patients were anxious or in pain. Baseline haemodynamic measurement was done two minutes after premedication. Spinal anesthesia was performed while patients in sitting position at L3-4 or L4-5 level with median or paramedian approach, with total dose 2,5 ml of 10 mg bupivacaine hyperbaric 0,5% and fentanyl 25 mcg. After skin wheal of lidocaine at the intended spinous interspace were placed, spinal needle (SpinocanR, B Braun, 27 G) were inserted and advanced until subarachnoid space were reached. In group FD, 1,5 ml of total dose followed by 1 ml remaining dose after 90 s interval were given. In SD group, 2,5 ml total dose were given with 0.2 ml/second rate, and subjects were asked to remain sitted for 90 seconds. If there were more than three injection attempts, the patients were excluded from the study. Co-loading 5 - 10 ml/kg ringer lactate in 20 minutes were given for all subjects.

Study Design

Study Type:
Interventional
Actual Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Comparative Study of Fractionated Vs Single Dose Injection for Spinal Anesthesia During Caesarean Section in Patients With Pregnancy-Induced Hypertension
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Apr 30, 2018
Actual Study Completion Date :
May 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Single dose (SD)

2,5 ml total anesthetic drug dose (Bupivacaine-fentanyl) were given with 0.2 ml/second rate, and subjects were asked to remain sitted for 90 seconds

Drug: Bupivacaine-fentanyl
2,5 ml total anesthetic drug dose were given with 0.2 ml/second rate, and subjects were asked to remain sitted for 90 seconds

Active Comparator: Fractionated dose (FD)

1,5 ml of total anesthetic drug dose (Bupivacaine-fentanyl) followed by 1 ml remaining dose after 90 s interval were given

Drug: Bupivacaine-fentanyl
1,5 ml of total anesthetic drug dose followed by 1 ml remaining dose after 90 s interval were given

Outcome Measures

Primary Outcome Measures

  1. Change of mean arterial pressure (MAP) [15 minutes]

    drop of blood pressure more than 20% of baseline value, and were treated with ephedrine 5 - 10 mg which could be repeated if necessary

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • with hypertension in pregnancy (gestational hypertension or preeclampsia)

  • ASA II-III

  • aged 18 - 40 years

  • BMI 18.5 - 35 kg/m2

  • singleton pregnancy

  • would undergo spinal anesthesia for emergency or semi-emergency caesarean section

Exclusion Criteria:
  • chronic hypertension

  • eclampsia

  • pulmonary edema

  • cerebrovascular diseases

  • type-2 diabetes mellitus and gestational diabetes

  • placental abruption/previa/accreta

  • umbilical cord prolapse

  • gestational age <34 weeks

  • estimated fetal weight <=2.300 gram and >=4.000 gram

  • polyhydramnios

  • fetal distress

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo National Hospital Jakarta Pusat DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Alfan Mahdi Nugroho, Principal Investigator, Indonesia University
ClinicalTrials.gov Identifier:
NCT03693638
Other Study ID Numbers:
  • IndonesiaUAnes024
First Posted:
Oct 3, 2018
Last Update Posted:
Feb 5, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Alfan Mahdi Nugroho, Principal Investigator, Indonesia University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 5, 2019